These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12872306)

  • 21. The analysis of placement values for evaluating discriminatory measures.
    Pepe MS; Cai T
    Biometrics; 2004 Jun; 60(2):528-35. PubMed ID: 15180681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Semi-parametric ROC regression analysis with placement values.
    Cai T
    Biostatistics; 2004 Jan; 5(1):45-60. PubMed ID: 14744827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of non-parametric confidence intervals for the area under the ROC curve of a continuous-scale diagnostic test.
    Gengsheng Qin ; Hotilovac L
    Stat Methods Med Res; 2008 Apr; 17(2):207-21. PubMed ID: 18426855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An ROC-type measure of diagnostic accuracy when the gold standard is continuous-scale.
    Obuchowski NA
    Stat Med; 2006 Feb; 25(3):481-93. PubMed ID: 16287217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ROC and loss function analysis in sequential testing.
    Muijtjens AM; Van Luijk SJ; Van Der Vleuten CP
    Adv Health Sci Educ Theory Pract; 2006 Feb; 11(1):5-17. PubMed ID: 16583280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Empirical likelihood inference for the area under the ROC curve.
    Qin G; Zhou XH
    Biometrics; 2006 Jun; 62(2):613-22. PubMed ID: 16918927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-type natriuretic peptide testing for structural heart disease screening: a general population-based study.
    Nakamura M; Tanaka F; Sato K; Segawa T; Nagano M
    J Card Fail; 2005 Dec; 11(9):705-12. PubMed ID: 16360967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples.
    Schisterman EF; Perkins NJ; Liu A; Bondell H
    Epidemiology; 2005 Jan; 16(1):73-81. PubMed ID: 15613948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bivariate random effects meta-analysis of ROC curves.
    Arends LR; Hamza TH; van Houwelingen JC; Heijenbrok-Kal MH; Hunink MG; Stijnen T
    Med Decis Making; 2008; 28(5):621-38. PubMed ID: 18591542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statistical correction of the area under the ROC curve in the presence of random measurement error and applications to biomarkers of oxidative stress.
    Schisterman EF
    Methods Mol Biol; 2002; 186():313-7. PubMed ID: 12013782
    [No Abstract]   [Full Text] [Related]  

  • 31. Application of the time-dependent ROC curves for prognostic accuracy with multiple biomarkers.
    Zheng Y; Cai T; Feng Z
    Biometrics; 2006 Mar; 62(1):279-87. PubMed ID: 16542256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonparametric estimation of ROC curves in the absence of a gold standard.
    Zhou XH; Castelluccio P; Zhou C
    Biometrics; 2005 Jun; 61(2):600-9. PubMed ID: 16011710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The agreement chart as an alternative to the receiver-operating characteristic curve for diagnostic tests.
    Bangdiwala SI; Haedo AS; Natal ML; Villaveces A
    J Clin Epidemiol; 2008 Sep; 61(9):866-74. PubMed ID: 18687288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A modified sign test for comparing paired ROC curves.
    Braun TM; Alonzo TA
    Biostatistics; 2008 Apr; 9(2):364-72. PubMed ID: 17925302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining diagnostic test results to increase accuracy.
    Pepe MS; Thompson ML
    Biostatistics; 2000 Jun; 1(2):123-40. PubMed ID: 12933515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
    Correia LC; Lima JC; Rocha MS; D'Oliveira Junior A; Péricles Esteves J
    Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction.
    Wu AH; Smith A; Christenson RH; Murakami MM; Apple FS
    Clin Chim Acta; 2004 Aug; 346(2):211-9. PubMed ID: 15256323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bayesian semi-parametric ROC analysis.
    Erkanli A; Sung M; Costello EJ; Angold A
    Stat Med; 2006 Nov; 25(22):3905-28. PubMed ID: 16416403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
    Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
    Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining multiple markers for classification using ROC.
    Ma S; Huang J
    Biometrics; 2007 Sep; 63(3):751-7. PubMed ID: 17825007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.